These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

185 related articles for article (PubMed ID: 35915245)

  • 41. Circular RNA hsa_circ_0004872 inhibits gastric cancer progression via the miR-224/Smad4/ADAR1 successive regulatory circuit.
    Ma C; Wang X; Yang F; Zang Y; Liu J; Wang X; Xu X; Li W; Jia J; Liu Z
    Mol Cancer; 2020 Nov; 19(1):157. PubMed ID: 33172486
    [TBL] [Abstract][Full Text] [Related]  

  • 42. WTAP enhances the instability of SYTL1 mRNA caused by YTHDF2 in bladder cancer.
    Wang J; Luo J; Wu X; Li Z
    Histol Histopathol; 2024 May; 39(5):633-646. PubMed ID: 37933909
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Casp8 acts through A20 to inhibit PD-L1 expression: The mechanism and its implication in immunotherapy.
    Zou J; Xia H; Zhang C; Xu H; Tang Q; Zhu G; Li J; Bi F
    Cancer Sci; 2021 Jul; 112(7):2664-2678. PubMed ID: 33934451
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Puerarin Inhibits the Progression of Bladder Cancer by Regulating circ_0020394/miR-328-3p/NRBP1 Axis.
    Du L; Zhang L; Sun F
    Cancer Biother Radiopharm; 2022 Aug; 37(6):435-450. PubMed ID: 33016781
    [No Abstract]   [Full Text] [Related]  

  • 45. circ_100984-miR-432-3p axis regulated c-Jun/YBX-1/β-catenin feedback loop promotes bladder cancer progression.
    Tong L; Yang H; Xiong W; Tang G; Zu X; Qi L
    Cancer Sci; 2021 Apr; 112(4):1429-1442. PubMed ID: 33314480
    [TBL] [Abstract][Full Text] [Related]  

  • 46. A scoping review on the potentiality of PD-L1-inhibiting microRNAs in treating colorectal cancer: Toward single-cell sequencing-guided biocompatible-based delivery.
    Shadbad MA; Asadzadeh Z; Derakhshani A; Hosseinkhani N; Mokhtarzadeh A; Baghbanzadeh A; Hajiasgharzadeh K; Brunetti O; Argentiero A; Racanelli V; Silvestris N; Baradaran B
    Biomed Pharmacother; 2021 Nov; 143():112213. PubMed ID: 34560556
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Cisplatin enhances NK cells immunotherapy efficacy to suppress HCC progression via altering the androgen receptor (AR)-ULBP2 signals.
    Shi L; Lin H; Li G; Sun Y; Shen J; Xu J; Lin C; Yeh S; Cai X; Chang C
    Cancer Lett; 2016 Apr; 373(1):45-56. PubMed ID: 26805759
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Circ-BPTF promotes bladder cancer progression and recurrence through the miR-31-5p/RAB27A axis.
    Bi J; Liu H; Cai Z; Dong W; Jiang N; Yang M; Huang J; Lin T
    Aging (Albany NY); 2018 Aug; 10(8):1964-1976. PubMed ID: 30103209
    [TBL] [Abstract][Full Text] [Related]  

  • 49. An inhibitor of programmed death ligand 1 enhances natural killer cell-mediated immunity against malignant melanoma cells.
    Lee YS; Heo W; Choi HJ; Cho HR; Nam JH; Ki YG; Lee HR; Son WC; Park YS; Kang CD; Bae J
    PLoS One; 2021; 16(4):e0248870. PubMed ID: 33793576
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Circ_0014235 confers Gefitinib resistance and malignant behaviors in non-small cell lung cancer resistant to Gefitinib by governing the miR-146b-5p/YAP/PD-L1 pathway.
    Niu R; Li D; Chen J; Zhao W
    Cell Cycle; 2022 Jan; 21(1):86-100. PubMed ID: 34919024
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Circular RNA circ_0000515 adsorbs miR-542-3p to accelerate bladder cancer progression via up-regulating ILK expression.
    Peng G; Guan J; Leng P; Peng L; Cao M; Feng Y
    Aging (Albany NY); 2022 Jan; 14(1):430-442. PubMed ID: 35029589
    [TBL] [Abstract][Full Text] [Related]  

  • 52. YY1-induced long non-coding RNA PSMA3 antisense RNA 1 functions as a competing endogenous RNA for microRNA 214-5p to expedite the viability and restrict the apoptosis of bladder cancer cells via regulating programmed cell death-ligand 1.
    Zhang M; Xu Y; Yin S; Qiu F
    Bioengineered; 2021 Dec; 12(2):9150-9161. PubMed ID: 34720049
    [TBL] [Abstract][Full Text] [Related]  

  • 53. "Built-in" PD-1 blocker to rescue NK-92 activity from PD-L1-mediated tumor escape mechanisms.
    Mensali N; Dillard P; Fayzullin A; Köksal H; Gaudernack G; Kvalheim G; Inderberg EM; Wälchli S
    FASEB J; 2021 Sep; 35(9):e21750. PubMed ID: 34424568
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Androgen receptor and immune cell PD-L1 expression in bladder tumors predicts disease recurrence and survival.
    Toren P; Brisson H; Simonyan D; Hovington H; Lacombe L; Bergeron A; Fradet Y
    World J Urol; 2021 May; 39(5):1549-1558. PubMed ID: 32676741
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Circular RNA hsa_circ_0000190 Facilitates the Tumorigenesis and Immune Evasion by Upregulating the Expression of Soluble PD-L1 in Non-Small-Cell Lung Cancer.
    Luo YH; Yang YP; Chien CS; Yarmishyn AA; Adekunle Ishola A; Chien Y; Chen YM; Tsai PH; Lin TW; Wang ML; Chiou SH
    Int J Mol Sci; 2021 Dec; 23(1):. PubMed ID: 35008490
    [TBL] [Abstract][Full Text] [Related]  

  • 56. circ_0089153 exacerbates breast cancer cells proliferation and metastasis via sponging miR-2467-3p/E2F6.
    Gao SL; Fan Y; Liu XD; Liu W; Zhao M
    Environ Toxicol; 2022 Jun; 37(6):1458-1471. PubMed ID: 35225430
    [TBL] [Abstract][Full Text] [Related]  

  • 57. KDM1A Promotes Immunosuppression in Hepatocellular Carcinoma by Regulating PD-L1 through Demethylating MEF2D.
    Wang Y; Cao K
    J Immunol Res; 2021; 2021():9965099. PubMed ID: 34307695
    [TBL] [Abstract][Full Text] [Related]  

  • 58. The Long Non-Coding RNA XIST Interacted with MiR-124 to Modulate Bladder Cancer Growth, Invasion and Migration by Targeting Androgen Receptor (AR).
    Xiong Y; Wang L; Li Y; Chen M; He W; Qi L
    Cell Physiol Biochem; 2017; 43(1):405-418. PubMed ID: 28869948
    [TBL] [Abstract][Full Text] [Related]  

  • 59. LncRNA PSMB8-AS1 contributes to pancreatic cancer progression via modulating miR-382-3p/STAT1/PD-L1 axis.
    Zhang H; Zhu C; He Z; Chen S; Li L; Sun C
    J Exp Clin Cancer Res; 2020 Sep; 39(1):179. PubMed ID: 32891166
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Inhibition of IL-6-JAK/Stat3 signaling in castration-resistant prostate cancer cells enhances the NK cell-mediated cytotoxicity via alteration of PD-L1/NKG2D ligand levels.
    Xu L; Chen X; Shen M; Yang DR; Fang L; Weng G; Tsai Y; Keng PC; Chen Y; Lee SO
    Mol Oncol; 2018 Mar; 12(3):269-286. PubMed ID: 28865178
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.